Recently discovered is that MDM2 has been found to disrupt the function of p53 via blocking p53 transcriptional activity and p53 protein degradation; such inconsistent activity of MDM2 for suppression of p53 expression is related to the higher progression of various types of malignancies, especially brain cancer [20,21,22]. This evidence concerns the gene MDM2 and brain cancer.